60 Degrees Pharmaceuticals Inc
60degreespharma.comWhat Do They Do?
Sells Arakoda, a malaria-prevention medicine, to pharmaceutical resellers and develops therapies for infectious diseases.
10-K for FY2025, filed Mar 30, 2026
How Do They Make Money?
The company sells Arakoda to resellers, with U.S. sales tied to shipped product the distributor takes ownership of and overseas sales to product shipments. Research-contract payments reimburse eligible costs as they are incurred.
10-K for FY2025, filed Mar 30, 2026
$1M
-
10-K for FY2025, filed Mar 30, 2026
$1M ↗
Who Are Their Customers?
It sells Arakoda through U.S. and overseas pharmaceutical distributors, with U.S. product moving through a third-party logistics partner, wholesalers and pharmacy benefit managers. It also does supply-chain research work for the U.S. Army Medical Materiel Development Activity.
10-K for FY2025, filed Mar 30, 2026We receive the majority of our product revenues from sales of our Arakoda product to resellers in the U.S. and abroad. Foreign sales to…View ↗
Other operating revenues for the periods presented include research revenue earned from the Australian Tax Authority for research…View ↗
We offer discounts and rebates to the civilian U.S. supply chain distribution channel. We record sales when our 3PL partner transfers boxes…View ↗
Do Revenues Turn Into Profits?
No. It lost $7.4M in FY2025.
10-K for FY2025, filed Mar 30, 2026
−$7.8MView ↗
10-K for FY2025, filed Mar 30, 2026
−$7.4MView ↗
10-K for FY2025, filed Mar 30, 2026
−$7MView ↗
How Are They Changing?
Loading...
